Atherosclerosis and Lipoproteins |
From the Lipid Research Center (C.C., J.-P.D., B.L., J.B.) and the Laboratory of Molecular Endocrinology (J.G.), Laval University Medical Research Center, CHUL Pavilion, Sainte-Foy, Québec, Canada; the Physical Activity Sciences Laboratory (J.G.), Department of Kinesiology, and the Department of Food Sciences and Nutrition (J.-P.D., B.L.), Laval University, Sainte-Foy, Québec, Canada; the Québec Heart Institute (J.-P.D.), Laval Hospital Research Center, Sainte-Foy, Québec, Canada; the School of Kinesiology and Leisure Studies (A.S.L.), University of Minnesota, Minneapolis; the Division of Biostatistics (D.C.R.), Washington University Medical School, St. Louis, Mo; the Department of Kinesiology (J.S.S.), Indiana University, Bloomington; the Department of Health and Kinesiology (J.H.W.), Texas A&M University, College Station; and the Pennington Biomedical Research Center (C.B.), Louisiana State University, Baton Rouge.
Correspondence to Jean-Pierre Després, PhD, Québec Heart Institute, Pavilion Mallet, 2nd Floor, 2725 chemin Sainte-Foy, Sainte-Foy, Québec, Canada G1V 4G5. E-mail Jean-Pierre.Despres{at}crchul.ulaval.ca
AbstractHigh
density lipoprotein (HDL) cholesterol concentrations have
been shown to increase with regular endurance exercise and, therefore,
can contribute to a lower risk of coronary heart disease in
physically active individuals compared with sedentary subjects.
Although low HDL cholesterol levels are frequently observed
in combination with hypertriglyceridemia,
some individuals may be characterized by isolated
hypoalphalipoproteinemia, ie, low HDL cholesterol levels in
the absence of elevated triglyceride (TG) concentrations.
The present study compared the responses of numerous
lipoprotein-lipid variables to a 20-week endurance exercise
training program in men categorized on the basis of baseline TG and HDL
cholesterol concentrations: (1) low TG and high HDL
cholesterol (normolipidemia), (2) low TG and low HDL
cholesterol (isolated low HDL cholesterol), (3)
high TG and high HDL cholesterol (isolated high TGs), and
(4) high TGs and low HDL cholesterol (high TG/low HDL
cholesterol). A series of physical and
metabolic variables was measured before and after the
training program in a sample of 200 men enrolled in the Health,
Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study.
At baseline, men with high TG/low HDL cholesterol had more
visceral adipose tissue than did men with isolated low HDL
cholesterol and men with normolipidemia. The 0.4% (not
significant) exercise-induced increase in HDL cholesterol
levels in men with isolated low HDL cholesterol suggests
that they did not benefit from the "HDL-raising" effect of
exercise. In contrast, men with high TG/low HDL cholesterol
showed a significant increase in HDL cholesterol levels
(4.9%, P<0.005). Whereas both
subgroups of men with elevated TG levels showed reductions in plasma
TGs (
-15.0%, P<0.005),
only those with high TG/low HDL cholesterol showed
significantly reduced apolipoprotein B levels at the end of the study
(-6.0%, P<0.005). Multiple
regression analyses revealed that the exercise-induced change
in abdominal subcutaneous adipose tissue (10.6%,
P<0.01) was the only
significant correlate of the increase in plasma HDL
cholesterol with training in men with high TG/low HDL
cholesterol. Results of the present study suggest that
regular endurance exercise training may be particularly helpful in men
with low HDL cholesterol, elevated TGs, and abdominal
obesity.
Key Words: HDL cholesterol triglycerides exercise training coronary heart disease
This article has been cited by other articles:
![]() |
V. Ouellet, S. J. Weisnagel, J. Marois, J. Bergeron, P. Julien, R. Gougeon, A. Tchernof, B. J. Holub, and H. Jacques Dietary Cod Protein Reduces Plasma C-Reactive Protein in Insulin-Resistant Men and Women J. Nutr., December 1, 2008; 138(12): 2386 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Hausenloy and D M Yellon Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels Postgrad. Med. J., November 1, 2008; 84(997): 590 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Blaha, S. Bansal, R. Rouf, S. H. Golden, R. S. Blumenthal, and A. P. DeFilippis A Practical 'ABCDE' Approach to the Metabolic Syndrome Mayo Clin. Proc., August 1, 2008; 83(8): 932 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Hausenloy and D M Yellon Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels Heart, June 1, 2008; 94(6): 706 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Motard-Belanger, A. Charest, G. Grenier, P. Paquin, Y. Chouinard, S. Lemieux, P. Couture, and B. Lamarche Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease Am. J. Clinical Nutrition, March 1, 2008; 87(3): 593 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Slentz, J. A. Houmard, J. L. Johnson, L. A. Bateman, C. J. Tanner, J. S. McCartney, B. D. Duscha, and W. E. Kraus Inactivity, exercise training and detraining, and plasma lipoproteins. STRRIDE: a randomized, controlled study of exercise intensity and amount J Appl Physiol, August 1, 2007; 103(2): 432 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Taylor Evidence to support aggressive management of HDL-cholesterol: implications of recent trials Eur. Heart J. Suppl., October 1, 2006; 8(suppl_F): F74 - F80. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lopez-Soriano, C. Chiellini, M. Maffei, P. A. Grimaldi, and J. M. Argiles Roles of Skeletal Muscle and Peroxisome Proliferator-Activated Receptors in the Development and Treatment of Obesity Endocr. Rev., May 1, 2006; 27(3): 318 - 329. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tsintsifa, P. Faxantidis, A. Tsiligkiroglou-Fachantidou, and A. Deligiannis Interactions Among Habitual Physical Activity, Eating Patterns, and Diet Composition Angiology, March 1, 2006; 57(2): 205 - 209. [Abstract] [PDF] |
||||
![]() |
I. L. Ruel, B. Lamarche, J.-F. Mauger, K. O. Badellino, J. S. Cohn, M. Marcil, and P. Couture Effect of Fenofibrate on Plasma Lipoprotein Composition and Kinetics in Patients With Complete Hepatic Lipase Deficiency Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2600 - 2607. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fletcher, K. Berra, P. Ades, L. T. Braun, L. E. Burke, J. L. Durstine, J. M. Fair, G. F. Fletcher, D. Goff, L. L. Hayman, et al. Managing Abnormal Blood Lipids: A Collaborative Approach Circulation, November 15, 2005; 112(20): 3184 - 3209. [Abstract] [Full Text] [PDF] |
||||
![]() |
2nd International Symposium on Triglycerides and HDL: Lipid abnormalities and their treatment Diabetes Care, November 1, 2005; 28(11): 2795 - 2802. [Full Text] [PDF] |
||||
![]() |
M. D. Ashen and R. S. Blumenthal Low HDL Cholesterol Levels N. Engl. J. Med., September 22, 2005; 353(12): 1252 - 1260. [Full Text] [PDF] |
||||
![]() |
P. T. Williams, P. J. Blanche, and R. M. Krauss Behavioral Versus Genetic Correlates of Lipoproteins and Adiposity in Identical Twins Discordant for Exercise Circulation, July 19, 2005; 112(3): 350 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shepherd Raising HDL-cholesterol and lowering CHD risk: does intervention work? Eur. Heart J. Suppl., July 1, 2005; 7(suppl_F): F15 - F22. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Costanza, E. Cayanis, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and A. Morabia Relative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population Am. J. Epidemiol., April 15, 2005; 161(8): 714 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Piche, S. J. Weisnagel, L. Corneau, A. Nadeau, J. Bergeron, and S. Lemieux Contribution of Abdominal Visceral Obesity and Insulin Resistance to the Cardiovascular Risk Profile of Postmenopausal Women Diabetes, March 1, 2005; 54(3): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-E. Piche, J.-F. Arcand-Bosse, J.-P. Despres, L. Perusse, S. Lemieux, and S. J. Weisnagel What is a Normal Glucose Value?: Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose Diabetes Care, October 1, 2004; 27(10): 2470 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Ruel, P. Couture, J. S. Cohn, A. Bensadoun, M. Marcil, and B. Lamarche Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism J. Lipid Res., August 1, 2004; 45(8): 1528 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Petibois, A. Cassaigne, H. Gin, and G. Deleris Lipid Profile Disorders Induced by Long-Term Cessation of Physical Activity in Previously Highly Endurance-Trained Subjects J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3377 - 3384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Hokanson, M. I. Kamboh, S. Scarboro, R. H. Eckel, and R. F. Hamman Effects of the Hepatic Lipase Gene and Physical Activity on Coronary Heart Disease Risk Am. J. Epidemiol., November 1, 2003; 158(9): 836 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Morabia, E. Cayanis, M. C. Costanza, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and T. C. Gilliam Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors Hum. Mol. Genet., November 1, 2003; 12(21): 2733 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Thompson, D. Buchner, I. L. Pina, G. J. Balady, M. A. Williams, B. H. Marcus, K. Berra, S. N. Blair, F. Costa, B. Franklin, et al. Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease: A Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): e42 - 49. [Full Text] [PDF] |
||||
![]() |
I. L. Ruel, P. Couture, C. Gagne, Y. Deshaies, J. Simard, R. A. Hegele, and B. Lamarche Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians J. Lipid Res., August 1, 2003; 44(8): 1508 - 1514. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Thompson, D. Buchner, I. L. Pina, G. J. Balady, M. A. Williams, B. H. Marcus, K. Berra, S. N. Blair, F. Costa, B. Franklin, et al. Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease: A Statement From the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity) Circulation, June 24, 2003; 107(24): 3109 - 3116. [Full Text] [PDF] |
||||
![]() |
W. J. Banz, M. A. Maher, W. G. Thompson, D. R. Bassett, W. Moore, M. Ashraf, D. J. Keefer, and M. B. Zemel Effects of Resistance versus Aerobic Training on Coronary Artery Disease Risk Factors Experimental Biology and Medicine, April 1, 2003; 228(4): 434 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Tall Exercise to Reduce Cardiovascular Risk -- How Much Is Enough? N. Engl. J. Med., November 7, 2002; 347(19): 1522 - 1524. [Full Text] [PDF] |
||||
![]() |
M. S. Bernstein, M. C. Costanza, R. W. James, M. A. Morris, F. Cambien, S. Raoux, and A. Morabia Physical Activity May Modulate Effects of ApoE Genotype on Lipid Profile Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 133 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Thompson and D. J. Rader Does Exercise Increase HDL Cholesterol in Those Who Need It the Most? Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1097 - 1098. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |